WakeMed Executives Advocate for Atrium Health Partnership Amid Financial Challenges
WakeMed executives, including CEO Donald R. Gintzig and Board Chair Thad L. McDonald, are advocating for a partnership with Atrium Health to strengthen their financial position. Despite a reported operating surplus of $135 million on $2.3 billion in revenue for the 2024 fiscal year, WakeMed faces financial challenges due to slim operating margins and past negative margins in 2022 and 2023. The executives argue that without a partnership, WakeMed may struggle against larger hospital systems, insurance companies, and pharmaceutical companies, especially with unpredictable changes in government healthcare policies. They emphasize that maintaining financial strength is crucial to avoid higher costs and lower-quality care for patients. 
